This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Goodbody Health Past Earnings Performance

Past criteria checks 0/6

Key information

-0.6%

Earnings growth rate

7.6%

EPS growth rate

Pharmaceuticals Industry Growth7.3%
Revenue growth rate91.0%
Return on equity-68.2%
Net Margin-22.6%
Last Earnings Update30 Sep 2022

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Goodbody Health makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:A3DTP0 Revenue, expenses and earnings (GBP Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2216-490
30 Jun 2220-2100
31 Mar 2221-2100
31 Dec 2117-290
30 Sep 2111-380
30 Jun 216-460
31 Mar 213-560
31 Dec 202-560
30 Sep 202-550
30 Jun 202-550
31 Mar 202-440
31 Dec 191-440
30 Sep 191-330
30 Jun 191-330
31 Mar 191-220
31 Dec 180-220

Quality Earnings: A3DTP0 is currently unprofitable.

Growing Profit Margin: A3DTP0 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: A3DTP0 is unprofitable, and losses have increased over the past 5 years at a rate of 0.6% per year.

Accelerating Growth: Unable to compare A3DTP0's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: A3DTP0 is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (22.1%).


Return on Equity

High ROE: A3DTP0 has a negative Return on Equity (-68.24%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2022/11/16 07:37
End of Day Share Price 2022/08/19 00:00
Earnings2022/09/30
Annual Earnings2021/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Goodbody Health Limited is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Ian JerminAllenby Capital Limited
John-Marc BunceCavendish Historical (Cenkos Securities)
Siddharth RajeevFundamental Research Corp.